Ravenquest Biomed Stock Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Ravenquest Biomed are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ravenquest Biomed has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Ravenquest Biomed is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 3.4 M | |
| Total Cashflows From Investing Activities | -28.5 M |
Ravenquest |
Ravenquest Biomed Relative Risk vs. Return Landscape
If you would invest 0.00 in Ravenquest Biomed on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Ravenquest Biomed or generate 0.0% return on investment over 90 days. Ravenquest Biomed is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Ravenquest, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ravenquest Biomed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ravenquest Biomed's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Ravenquest Biomed, and traders can use it to determine the average amount a Ravenquest Biomed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| RVVQF |
Based on monthly moving average Ravenquest Biomed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ravenquest Biomed by adding Ravenquest Biomed to a well-diversified portfolio.
Ravenquest Biomed Fundamentals Growth
Ravenquest Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ravenquest Biomed, and Ravenquest Biomed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ravenquest Pink Sheet performance.
| Return On Equity | -1.12 | |||
| Return On Asset | -0.19 | |||
| Operating Margin | (9.06) % | |||
| Current Valuation | 11.72 M | |||
| Shares Outstanding | 123.62 M | |||
| Price To Book | 0.03 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 1.26 M | |||
| EBITDA | (27.26 M) | |||
| Cash And Equivalents | 749.13 K | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 0.72 % | |||
| Book Value Per Share | 0.17 X | |||
| Cash Flow From Operations | (11.1 M) | |||
| Earnings Per Share | (0.22) X | |||
| Total Asset | 37.7 M | |||
About Ravenquest Biomed Performance
By analyzing Ravenquest Biomed's fundamental ratios, stakeholders can gain valuable insights into Ravenquest Biomed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ravenquest Biomed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ravenquest Biomed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada. RAVENQUEST BIOMED operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange.Things to note about Ravenquest Biomed performance evaluation
Checking the ongoing alerts about Ravenquest Biomed for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ravenquest Biomed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ravenquest Biomed generated a negative expected return over the last 90 days | |
| Ravenquest Biomed has some characteristics of a very speculative penny stock | |
| The company has a current ratio of 0.48, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ravenquest Biomed until it has trouble settling it off, either with new capital or with free cash flow. So, Ravenquest Biomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ravenquest Biomed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ravenquest to invest in growth at high rates of return. When we think about Ravenquest Biomed's use of debt, we should always consider it together with cash and equity. | |
| Ravenquest Biomed reported the revenue of 1.26 M. Net Loss for the year was (30.47 M) with profit before overhead, payroll, taxes, and interest of 801.29 K. | |
| Ravenquest Biomed has accumulated about 749.13 K in cash with (11.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
- Analyzing Ravenquest Biomed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ravenquest Biomed's stock is overvalued or undervalued compared to its peers.
- Examining Ravenquest Biomed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ravenquest Biomed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ravenquest Biomed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ravenquest Biomed's pink sheet. These opinions can provide insight into Ravenquest Biomed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ravenquest Pink Sheet analysis
When running Ravenquest Biomed's price analysis, check to measure Ravenquest Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ravenquest Biomed is operating at the current time. Most of Ravenquest Biomed's value examination focuses on studying past and present price action to predict the probability of Ravenquest Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ravenquest Biomed's price. Additionally, you may evaluate how the addition of Ravenquest Biomed to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |